Mesothelioama Claims

Google+ Pinterest LinkedIn Tumblr +

Mesothelioma Claims, Paul Kraus is not the only long-term survivor of malignant mesothelioma. There are others. We have heard about them and spoken to some over the years. What is fascinating is that many of these malignant mesothelioma survivors have something in common – they have all taken steps to improve or enhance their immune system. Some used alternative or complimentary therapies (with guidance from licensed clinicians) while others participated in clinical trials of immune therapy.

Mesothelioma Claims

Mesothelioma Claims, This raises the question – does the immune system play a role in controlling malignant mesothelioma? Paul Kraus’ experience and those of other long-term malignant mesothelioma survivors suggests that such a role may be possible.

Mesothelioma Claims

Mesothelioma Claims, In other sections of this website we present case histories of malignant mesothelioma survivors who were diagnosed with either pleural mesothelioma or peritoneal mesothelioma. In some of the pleural mesothelioma case histories, doctors discuss the role that the patient’s immune system may have played in their extremely long survival.

Mesothelioma Claims

Mesothelioma Claims,  In 1986, an article appeared in a medical journal that discussed this very issue of malignant mesothelioma and immunity.(1)  This research focused on the immune responses of 118 healthy people compared to 20 patients with malignant mesothelioma and 375 long-term asbestos workers who were cancer-free.

Mesothelioma Claims

Mesothelioma Claims, The researchers wanted to know if there were any measurable differences in the immune responses of the mesothelioma patients.  Their findings demonstrated a relationship between the immune system and malignant mesothelioma.  For example, Mesothelioma Claims.

Mesothelioma Claims, Because of this danger, GM is no stranger to asbestos-related lawsuits and mesothelioma claims.  According to Bloomberg Business Week, during the 1990’s the average annual asbestos-related indemnity costs were around $2 million and the company saw fewer than 40 mesothelioma claims per year.  But those figures rose steadily during the following decade, ballooning to an annual average of $30 million in indemnity costs and 850 claims each year from 2000 to 2008.

Mesothelioma Claims

Mesothelioma Claims, GM’s creditors want to gather data to determine what levels to expect, going forward. U.S. Bankruptcy Judge Robert Gerber in New York granted the request for information from GM’s creditors, with the stipulation that the creditors must keep sensitive information confidential.  Although GM’s lawyers argued against the release of the data, Gerber decided in favor of release saying “This isn’t like the formula for Coke or nuclear launch codes.”


About Author

Leave A Reply